Abstract
Aim:
To investigate the effects of the agonists of proteinase activated receptor (PAR)-2, and histamine on degranulation of human mast cells.
Methods:
Human mast cells were enzymatically dispersed from tonsil and skin tissues. The dispersed cells were then cultured with various stimuli, and tryptase and histamine levels in cell supernatants collected from challenge tubes were measured.
Results:
PAR-2 agonist peptide SLIGKV provoked a dose-dependent release of histamine from skin mast cells. It also induced tryptase release from tonsil mast cells. tc-LIGRLO appeared less potent than SLIGKV in induction of release of histamine and tryptase. Trypsin was able to induce a “bell” shape increase in tryptase release from tonsil mast cells. It was also able to induce a dose-dependent release of histamine from both tonsil and skin mast cells. The actions of trypsin on mast cells were inhibited by soy bean trypsin inhibitor (SBTI) or α1-antitrypsin (α1-AT). Time course study revealed that both stimulated tryptase or histamine release initiated within 10 s and reached their peak release between 4 and 6 min. Pretreatment of cells with metabolic inhibitors or pertussis toxin reduced the ability of mast cells to release tryptase or histamine.
Conclusion:
It was demonstrated that the in vitro tryptase release properties of human tonsil and skin mast cells suggested a novel type of mast cell heterogeneity. The activation of mast cells by PAR-2 agonists indicated a self-amplification mechanism of mast cell degranulation.
Similar content being viewed by others
Article PDF
References
He S . The key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol 2004; 10: 309–18.
Walls AF, He S, Buckley MG, McEuen AR . Roles of the mast cell and basophil in asthma. Clin Exp Allergy Rev 2001; 1: 68–72.
He S, Chen HQ, Zheng J . Inhibition of tryptase and chymase induced nucleated cell infiltration by proteinase inhibitors. Acta Pharmacol Sin 2004; 25: 1677–84.
Schwartz LB . Preformed mediators of human mast cells and basophils. In: Holgate ST, editor. Mast cells, mediators and disease. Dordrect: Kluwer Academic Publishers; 1988. p 129–47.
McEuen AR, He S, Brander ML, Walls AF . Guinea pig lung tryptase: Localisation to mast cells and characterisation of the partially purified enzyme. Biochem Pharmacol 1996; 52: 331–40.
Okayama Y, Church MK . Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells. Int Arch Allergy Appl Immunol 1992; 97: 216–25.
Okayama Y, Benyon RC, Lowman MA, Church MK . In vitro effects of H1-antihistamine and PGD2 release from mast cells of human lung, tonsil, and skin. Allergy 1994; 49: 246–53.
Butchers PR, Vardey CJ, Johnson M . Salmeterol: a potent and longacting inhibitor of inflammatory mediator release from human lung. Br J Pharmacol 1991; 104: 67–26.
Molino M, Barnathan ES, Numerof R, Clark J, Dreyer M, Cumashi A, et al. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 1997; 272: 4043–9.
D'Andrea MR, Rogahn CJ, Andrade-Gordon P . Localization of protease-activated receptors-1 and -2 in human mast cells: indications for an amplified mast cell degranulation cascade. Biotech Histochem 2000; 75: 85–90.
Stenton GR, Nohara O, Dery RE, Vliagoftis H, Gilchrist M, Johri A, et al. Proteinase-activated receptor (PAR)-1 and -2 agonists induce mediator release from mast cells by pathways distinct from PAR-1 and PAR-2. J Pharmacol Exp Ther 2002; 302: 466–74.
He S, He Y, Xie H . Activation of human colon mast cells through proteinase activated receptor-2 (PAR-2). World J Gastroenterol 2004; 10: 327–31.
Hollenberg MD, Saifeddine M, al-Ani B, Kawabata A . Protein-ase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can J Physiol Pharmacol 1997; 75: 832–41.
He S, Xie H . Modulation of tryptase secretion from human colon mast cells by histamine. World J Gastroenterol 2004; 10: 323–26.
He S, Gaça MDA, Walls AF . A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase. J Pharmacol Exp Ther 1998; 286: 289–97.
He S, Xie H, Zhang XJ, Wang XJ . Inhibition of histamine release from human mast cells by natural chymase inhibitors. Acta Pharmacol Sin 2004; 25: 822–6.
He S, Chen P, Chen HQ . Modulation of enzymatic activity of human mast cell tryptase and chymase by proteinase inhibitors. Acta Pharmacol Sin 2003; 24: 923–9.
Buckley MG, Walters C, Brander M, Wong WM, Cawley MI, Ren S, et al. Mast cell activation in arthritis: detection of α- and β-tryptase, histamine and eosinophil cationic protein in synovial fluid. Clin Sci 1997; 93: 363–70.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the Planned Science and Technology Project of Guangdong Province, China, No 2003B31502, and the Li Ka Shing Foundation, Hong Kong, China, No C0200001.
Rights and permissions
About this article
Cite this article
He, Sh., Xie, H. & Fu, Yl. Activation of human tonsil and skin mast cells by agonists of proteinase activated receptor-2. Acta Pharmacol Sin 26, 568–574 (2005). https://doi.org/10.1111/j.1745-7254.2005.00079.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2005.00079.x
Keywords
This article is cited by
-
Role of TF-Triggered Activation of the Coagulation Cascade in the Pathogenesis of Chronic Spontaneous Urticaria
Current Treatment Options in Allergy (2018)
-
Downregulation of protease activated receptor expression and cytokine production in P815 cells by RNA interference
BMC Cell Biology (2009)
-
Modulation of mast cell proteinase‐activated receptor expression and IL‐4 release by IL‐12
Immunology & Cell Biology (2007)
-
Functional Characterization and Expression Analysis of the Proteinase-Activated Receptor-2 in Human Cutaneous Mast Cells
Journal of Investigative Dermatology (2006)